drugset / Trial / NCT03880825

Drug Interaction Study of Levoketoconazole and Metformin

NCT03880825

Phase 1 Completed 32 enrolled Cortendo AB
Non-randomizedSequentialOpen-labelOther

Summary

This is a phase I, open-label, fixed-sequence drug-drug interaction study to evaluate the effect of levoketoconazole on the single-dose PK of metformin in health subjects.

Timeline

Start
2019-03-28
Primary completion
2019-05-03
Completion
2019-05-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Levoketoconazole Unknown 150 mg
Subject Levoketoconazole Unknown 600 mg
Subject Metformin Small molecule 500 mg Oral

Indications

No indication recorded.